Brian Bonnell's Insider Trades & SAST Disclosures
Brian Bonnell's most recent trade in ICU Medical, Inc. was a trade of 3,248 Common Stock done . Disclosure was reported to the exchange on March 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brian Bonnell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 3,248 | 30,348 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 3,248 | 3,248 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 10,566 | 10,566 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,146 | 27,100 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,146 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 3,247 | 26,734 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 3,247 | 6,496 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.08 per share. | 15 Mar 2024 | 1,780 | 24,954 (0%) | 0% | 98.1 | 174,582 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 12,872 | 0 | - | - | Performance Shares | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 12,872 | 26,257 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 7,289 | 0 | - | - | Performance Shares | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 7,289 | 27,485 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.39 per share. | 07 Mar 2024 | 7,059 | 19,198 (0%) | 0% | 105.4 | 743,948 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.52 per share. | 07 Mar 2024 | 3,998 | 23,487 (0%) | 0% | 104.5 | 417,871 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,210 | 21,408 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,210 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,145 | 14,560 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,145 | 2,146 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.52 per share. | 07 Mar 2024 | 1,212 | 20,196 (0%) | 0% | 104.5 | 126,678 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.39 per share. | 07 Mar 2024 | 1,175 | 13,385 (0%) | 0% | 105.4 | 123,833 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 9,743 | 9,743 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 8,745 | 0 | - | - | Performance Shares | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 8,745 | 14,957 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.25 per share. | 06 Mar 2023 | 4,604 | 10,353 (0%) | 0% | 161.3 | 742,395 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 2,209 | 2,210 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 2,209 | 13,578 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 2,145 | 4,291 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 2,145 | 12,498 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 1,551 | 7,028 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 1,551 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.17 per share. | 06 Mar 2023 | 1,163 | 12,415 (0%) | 0% | 156.2 | 181,626 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.47 per share. | 06 Mar 2023 | 1,129 | 11,369 (0%) | 0% | 157.5 | 177,784 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.25 per share. | 06 Mar 2023 | 816 | 6,212 (0%) | 0% | 161.3 | 131,580 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2022 | 6,436 | 6,436 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 2,209 | 4,419 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 2,209 | 6,640 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,551 | 1,551 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,551 | 5,247 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Mar 2022 | 1,163 | 5,477 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 242.93 per share. | 06 Mar 2022 | 816 | 4,431 (0%) | 0% | 242.9 | 198,231 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 722 | 4,076 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 722 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 242.93 per share. | 06 Mar 2022 | 380 | 3,696 (0%) | 0% | 242.9 | 92,313 | Common Stock |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2021 | 6,628 | 6,628 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2021 | 1,550 | 3,102 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2021 | 1,550 | 3,598 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Mar 2021 | 816 | 2,782 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2021 | 722 | 2,428 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2021 | 722 | 722 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Mar 2021 | 380 | 2,048 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2020 | 1,208 | 1,553 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2020 | 1,208 | 1,208 | - | - | Common Stock | |
| ICU Medical, Inc. | Brian Bonnell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 14 Aug 2020 | 636 | 917 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges